Overview & Interdisciplinary Expertise
EUTROC (European Network for Translational Research in Ovarian Cancer) is a pan-European and global network of translational research in ovarian cancer.
We were established in 2013 to improve the current and future management of ovarian cancer and to bring the complex matrix into a single multi-disciplinary, translational framework. Since its inception, the network has now expanded to incorporate a number of global partners in the USA, Canada, Australia, China and India
EUTROC benefits from broad expertise in clinical as well as preclinical research, and is dedicated to improving the long-term clinical outcome of patients through development of effective diagnostic and treatment strategies around tumour biology; immunology; epigenetics; pathology; bioinformatics; drug development and delivery; and clinical trial development.
Principally in the context of complex Phase II clinical trials, our remit is to facilitate translational research and develop cutting edge therapies for ovarian cancer in order to bring promising drug candidates and treatments into clinical settings that are currently delayed by factors such as a lack of standardised protocols for preclinical animal studies, a lack of suitable ovarian cancer models and a lack of validated predictive biomarker diagnostics.
EUTROC exists to undertake translational research and education in ovarian and gynaecological cancer in order to accelerate benefit for patients with these conditions. The members of EUTROC will undertake coordinated translational research both within and out-with the context of clinical trials to achieve these aims. EUTROC will harmonise with other related organisations to achieve these aims to facilitate a change in depth and strength of patient focussed research to meet these aims.
Management & Structure
Learn more about the people behind Eutroc